189 related articles for article (PubMed ID: 21454491)
1. Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors.
Lavery DN; Villaronga MA; Walker MM; Patel A; Belandia B; Bevan CL
J Biol Chem; 2011 May; 286(20):17796-808. PubMed ID: 21454491
[TBL] [Abstract][Full Text] [Related]
2. Hairy and Enhancer of Split-Related With YRPW Motif-Like (HeyL) Is Dispensable for Bone Remodeling in Mice.
Canalis E; Zanotti S
J Cell Biochem; 2017 Jul; 118(7):1819-1826. PubMed ID: 28019674
[TBL] [Abstract][Full Text] [Related]
3. Hey basic helix-loop-helix transcription factors are repressors of GATA4 and GATA6 and restrict expression of the GATA target gene ANF in fetal hearts.
Fischer A; Klattig J; Kneitz B; Diez H; Maier M; Holtmann B; Englert C; Gessler M
Mol Cell Biol; 2005 Oct; 25(20):8960-70. PubMed ID: 16199874
[TBL] [Abstract][Full Text] [Related]
4. HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions.
Villaronga MA; Lavery DN; Bevan CL; Llanos S; Belandia B
Oncogene; 2010 Jan; 29(3):411-20. PubMed ID: 19802006
[TBL] [Abstract][Full Text] [Related]
5. Hey1, a mediator of notch signaling, is an androgen receptor corepressor.
Belandia B; Powell SM; García-Pedrero JM; Walker MM; Bevan CL; Parker MG
Mol Cell Biol; 2005 Feb; 25(4):1425-36. PubMed ID: 15684393
[TBL] [Abstract][Full Text] [Related]
6. Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer.
Katoh M; Katoh M
Int J Oncol; 2007 Aug; 31(2):461-6. PubMed ID: 17611704
[TBL] [Abstract][Full Text] [Related]
7. Hairy and Enhancer of Split-related with YRPW motif (HEY)2 regulates bone remodeling in mice.
Zanotti S; Canalis E
J Biol Chem; 2013 Jul; 288(30):21547-57. PubMed ID: 23782701
[TBL] [Abstract][Full Text] [Related]
8. TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth.
Daniels G; Li Y; Gellert LL; Zhou A; Melamed J; Wu X; Zhang X; Zhang D; Meruelo D; Logan SK; Basch R; Lee P
Endocr Relat Cancer; 2014 Feb; 21(1):127-42. PubMed ID: 24243687
[TBL] [Abstract][Full Text] [Related]
9. Hey1 and Hey2 are differently expressed during mouse tooth development.
Kibe K; Nakatomi M; Kataoka S; Toyono T; Seta Y
Gene Expr Patterns; 2018 Jan; 27():99-105. PubMed ID: 29155305
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional analysis of amino-terminal enhancer of split in androgen-receptor-driven transcription.
Zhang Y; Gao S; Wang Z
Biochem J; 2010 Apr; 427(3):499-511. PubMed ID: 20163360
[TBL] [Abstract][Full Text] [Related]
11. Target gene analysis by microarrays and chromatin immunoprecipitation identifies HEY proteins as highly redundant bHLH repressors.
Heisig J; Weber D; Englberger E; Winkler A; Kneitz S; Sung WK; Wolf E; Eilers M; Wei CL; Gessler M
PLoS Genet; 2012; 8(5):e1002728. PubMed ID: 22615585
[TBL] [Abstract][Full Text] [Related]
12. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB
Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366
[TBL] [Abstract][Full Text] [Related]
13. TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.
Kikuchi M; Okumura F; Tsukiyama T; Watanabe M; Miyajima N; Tanaka J; Imamura M; Hatakeyama S
Biochim Biophys Acta; 2009 Dec; 1793(12):1828-36. PubMed ID: 19909775
[TBL] [Abstract][Full Text] [Related]
14. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
[TBL] [Abstract][Full Text] [Related]
15. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
Yoon HG; Wong J
Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of epigenetic and cell-type specific regulation of Hey target genes in ES cells and cardiomyocytes.
Weber D; Heisig J; Kneitz S; Wolf E; Eilers M; Gessler M
J Mol Cell Cardiol; 2015 Feb; 79():79-88. PubMed ID: 25446183
[TBL] [Abstract][Full Text] [Related]
17. Ligand-dependent corepressor acts as a novel androgen receptor corepressor, inhibits prostate cancer growth, and is functionally inactivated by the Src protein kinase.
Asim M; Hafeez BB; Siddiqui IA; Gerlach C; Patz M; Mukhtar H; Baniahmad A
J Biol Chem; 2011 Oct; 286(43):37108-17. PubMed ID: 21856747
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids inhibit notch target gene expression in osteoblasts.
Zanotti S; Yu J; Adhikari S; Canalis E
J Cell Biochem; 2018 Jul; 119(7):6016-6023. PubMed ID: 29575203
[TBL] [Abstract][Full Text] [Related]
19. Repression of chondrogenesis through binding of notch signaling proteins HES-1 and HEY-1 to N-box domains in the COL2A1 enhancer site.
Grogan SP; Olee T; Hiraoka K; Lotz MK
Arthritis Rheum; 2008 Sep; 58(9):2754-63. PubMed ID: 18759300
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor PAX6 functions as androgen receptor co-repressor to inhibit prostate cancer growth.
Shyr CR; Tsai MY; Yeh S; Kang HY; Chang YC; Wong PL; Huang CC; Huang KE; Chang C
Prostate; 2010 Feb; 70(2):190-9. PubMed ID: 19790232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
